SCHEMBL7183816

SCHEMBL7183816

CC(C)Oc1c(C=CC(=O)c2ccc(C(=O)N(C)C)cc2)cc(C(C)C)cc1C(C)C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.38
LMNA P02545 1/20 0.38
MAPT P10636 1/20 0.38
RAB9A P51151 1/20 0.38
CXCL12 P48061 1/20 0.38
ABCG2 Q9UNQ0 3/20 0.37
CHRNA7 P36544 1/20 0.35
BCHE P06276 1/20 0.35
CTSL P07711 2/20 0.34
CTSB P07858 2/20 0.34
CAPN1 P07384 1/20 0.34
GABRA3 P34903 1/20 0.34
GABRA2 P47869 1/20 0.34
GABRB2 P47870 1/20 0.34
TNFRSF1A P19438 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
HDAC4 P56524 1/20 0.34
HDAC1 Q13547 1/20 0.34
KRAS P01116 1/20 0.34
PTPN1 P18031 3/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7184603 0.90 ABCG2 (0.44) KDM4ELMNAMAPTRAB9ACXCL12
SCHEMBL7182854 0.88 PTGS1 (0.41) KDM4ELMNAMAPT
SCHEMBL7179811 0.85 RXRA (0.43) LMNAMAPTABCG2
SCHEMBL7177356 0.82 ABCG2 (0.44) KDM4ELMNAMAPTRAB9ACXCL12
SCHEMBL7192165 0.80 ABCG2 (0.47) KDM4ELMNAMAPTABCG2CTSL
SCHEMBL7184621 0.80 CYP1A1 (0.41) MAPTABCG2CHRNA7BCHE
SCHEMBL7192169 0.80 ABCG2 (0.47) KDM4ELMNAMAPTABCG2CTSL
SCHEMBL7181421 0.77 LMNA (0.38) LMNAABCG2CHRNA7BCHECTSL
SCHEMBL7184330 0.76 TNFRSF1A (0.38) LMNAMAPTABCG2CHRNA7BCHE
SCHEMBL7188033 0.76 ABCG2 (0.57) KDM4ELMNAMAPTRAB9ACXCL12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6603046-B1 The invention is drawn to novel bis-aromatic a, beta -unsaturated ketones. The compounds are useful in the treatment and prophylaxis of diseases caused by parasites or bacteria. LICA PHARMACEUTICALS A/S (DK) 2003-08-05 US disclosed
EP-0634927-B1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA LICA PHARMACEUTICALS AS (DK) 2001-07-04 EP disclosed
US-5985935-A PARASITICIDES OR BACTERICIDES STATENS SERUMINSTITUT (DK) 1999-11-16 US disclosed